Antibody-drug conjugate approvals

BsAbs and peptide therapies saw four new entrants each, while ADCs, cell therapies, and fusion proteins received three approvals each.

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA

DIA. (2025). 2025 NMPA Approvals: China Clears Record Number of New Drugs. Retrieved September 17, 2026, from https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Via StatOrigin, https://statorigin.org/stat/stat_9SEHGAYSGEVZP40MYK9NVXJ81A

Copy

MLA

DIA. "2025 NMPA Approvals: China Clears Record Number of New Drugs." 2025, https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_9SEHGAYSGEVZP40MYK9NVXJ81A.

Copy

Chicago

DIA. "2025 NMPA Approvals: China Clears Record Number of New Drugs." 2025. https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_9SEHGAYSGEVZP40MYK9NVXJ81A.

Copy

BibTeX

@misc{dia2025antibodyvxj81a, author = {{DIA}}, title = {2025 NMPA Approvals: China Clears Record Number of New Drugs}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_9SEHGAYSGEVZP40MYK9NVXJ81A}, note = {Original source: https://globalforum.diaglobal.org/issue/march-2026/2025-nmpa-approvals-china-clears-record-number-of-new-drugs/. Accessed September 17, 2026.} }

Copy

Everything needed to check this number yourself, without taking our word for it.

Record last modified 17 September 2026. Value type: actual. Update cadence: annual. This page is permanently addressable at statorigin.org/stat/stat_9SEHGAYSGEVZP40MYK9NVXJ81A.